3,791 companies
2,409 AI summaries
1,867 risk analyses
1,334 growth scores
Register free — watchlist & alerts →
🔔 Get free email alerts on Daicel Corporation (4202)
AI summaries of Japanese EDINET filings — in English. Free, unsubscribe anytime.
- ✓ Email alert when 4202 files its next EDINET disclosure
- ✓ AI summary · sentiment · risk · growth (JA / EN)
- ✓ Free account: watchlist & alerts on all the stocks you follow
EDINET 4202 Neutral Risk Analyzed
Daicel Corporation
Extraordinary Report ／ 2026-06-23 11:42
Covers EDINET statutory filings (TDNET timely disclosures / earnings flashes are not included).
Dividend Up
AI Summary
2026-06-23 11:45
Daicel's 160th Annual General Meeting on June 19, 2026 approved a ¥30/share dividend, election of 11 directors and 3 auditors, and adoption of a performance-linked share compensation plan with strong shareholder support.
KEY POINTS
- Final dividend of ¥30 per share approved, maintaining 28% payout ratio
- Board and audit committee elections passed with high approval rates (79.7%–99.5%)
- Performance-linked share compensation plan introduced to enhance long-term value creation (99.26% approval)
📊 Revenue
N/A
💰 Operating profit
N/A
🔮 Outlook
Not stated
Risk and growth scores and tags are AI-generated estimates from analyzing the disclosure. They are not guarantees of fact, nor investment advice or recommendations. Make investment decisions at your own discretion.
⚠️ Extracted Risk Factors
| Category | Description | Score | New |
|---|---|---|---|
| Earnings Deterioration Risk | Q4 operating profit declined 31.0% YoY, signaling potential deterioration in core business profitability. | 7/10 | |
| Market Risk | Q4 revenue declined 1.2% YoY. Exposure to cyclical chemical industry demand fluctuations evident. | 6/10 | |
| Other Business Risk | Projected 214.3% net income recovery in FY2026 reflects prior-year special losses; sustainability unclear. | 5/10 |
7/10
Earnings Deterioration Risk
Q4 operating profit declined 31.0% YoY, signaling potential deterioration in core business profitability.
6/10
Market Risk
Q4 revenue declined 1.2% YoY. Exposure to cyclical chemical industry demand fluctuations evident.
5/10
Other Business Risk
Projected 214.3% net income recovery in FY2026 reflects prior-year special losses; sustainability unclear.
Track Japanese disclosures with JSIGNAL
AI summaries, risk & growth analysis, watchlist alerts and a screener for every Japanese listed company.
Start free — 30-day trial Login